WHO board of trustees calls for gene editing tools to be imparted to more poorer countries Kumar Jeetendra | July 12, 2021 A World Health Organization (WHO) committee said on Monday that human genome editing technologies to treat serious disease should be shared more generously, to allow poorer nations to benefit from the highly dynamic scientific field. “WHO should work with others to encourage relevant patent holders to help ensure equitable access to human genome editing interventions,” …
Hard-won increases in risk as Delta variant spreads: WHO Kumar Jeetendra | August 1, 2021 The world is at risk of losing hard-won gains in fighting COVID-19 as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective, the World Health Organization said on Friday. The U.S. Centers for Disease Control and Prevention (CDC) has described the Delta variant of the coronavirus as being as transmissible as chickenpox and …
New novel Covid variant revealed with very limited cases in France Kumar Jeetendra | January 5, 2022 While it is true that the Omicron version of coronavirus continues to spread to people in large numbers around the globe, news of the emerging of a second extremely mutated version was widely reported on Tuesday, triggering the possibility of another round of infection. The variation, B.1.640, has been discovered predominantly in France at this …
SEC suggests Covid-19 immunization Corbevax for 12 to 18 year age group: Report Kumar Jeetendra | February 15, 2022 The Drugs Controller General of India (DCGI)’s Subject Expert Committee (SEC) has recommended Emergency Use Authorization to Hyderabad-based pharmaceutical company Biological E’s COVID-19 vaccine, Corbevax, for the age group 12 to 18 years subject to certain conditions, official sources said. The country’s central drug authority is expected to give final approval to Corbevax, which is …
